Novo Nordisk A/S (NYSE:NVO)
During the Trading Day
| 161.87 |  +0.17 / +0.11% |
Data as of 4:02pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 161.86 |  -0.01 / -0.01% |
Volume: 3.7K |
Latest NVO News | Press Releases
| Positive Data on Novartis' Jakavi - Analyst Blog 5:24pm / Zacks.com | Encouraging Data on Novartis' Gilenya - Analyst Blog Jun 14 / Zacks.com |
| J&J to Buy Aragon for $1 Billion - Analyst Blog 11:20am / Zacks.com | Lilly Alzheimer's Study Terminated - Analyst Blog Jun 14 / Zacks.com |
| Why MannKind Is Poised to Pull Back 9:51am / MotleyFool.com | Sanofi's Fluzone Quadrivalent Gets FDA Nod - Analyst Blog Jun 13 / Zacks.com |
| Benzinga's Top Pre-Market Losers Jun 17 / Benzinga | CHMP Positive on Sanofi's Lantus - Analyst Blog Jun 11 / Zacks.com |
| 1 Thing You Always Wanted to Know About Drugs (but Were Afraid to Ask) Jun 14 / MotleyFool.com | Novo Nordisk A/S (NVO): Today's Featured Drugs Winner Jun 11 / TheStreet.com |
Today’s Trading
| Previous close | 161.70 |
| Today’s open | 162.37 |
| Day’s range | 161.78 - 163.02 |
| Volume | 243,917 |
| Average volume (3 months) | 261,159 |
| Market cap | $69.8B |
| Dividend yield | 1.97% |
Data as of 4:02pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | +19.33% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +13.80% |
| Revenue growth (last year) | +8.57% |
| P/E ratio | -- |
| Price/Sales | 6.61 |
| Price/Book | 12.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie Inc | +0.53 | +1.23% |
| AZNAstraZeneca PLC | +0.01 | +0.02% |
| BMYBristol-Myers Squibb... | +0.41 | +0.88% |
| LLYEli Lilly and Co | -0.01 | -0.02% |
Data as of 4:02pm ET, 06/18/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $2.11 |
| Annual revenue (last year) | $13.5B |
| Annual profit (last year) | $3.7B |
| Net profit margin | 27.47% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
President & Chief Executive Officer Lars Rebien Sørensen |
Chief Operating Officer & Executive Vice President Kåre Schultz |
Corporate headquarters Bagsværd, -- |
Forecasts
